This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Msn Laboratories Private Limited, R&d Center. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations of Srinivasulu Rangineni
Introduction
Srinivasulu Rangineni is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline polymorphs. With a total of 4 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
Rangineni's latest patents include innovative formulations that enhance the efficacy of existing compounds. One of his notable inventions is the crystalline polymorphs of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one. This invention relates to novel crystalline polymorphs and the process for their preparation. Another significant patent involves polymorphs of 4-[3-chloro-4-(N'-cyclopropyl ureido)phenoxy]-7-methoxyquinoline-6-carboxamide, including its salts and the process for their preparation. These advancements showcase his commitment to improving pharmaceutical formulations.
Career Highlights
Srinivasulu Rangineni is currently associated with MSN Laboratories Private Limited, R&D Center. His role in the company allows him to focus on research and development, contributing to innovative solutions in the pharmaceutical industry. His expertise in polymorph development is a testament to his skills and dedication.
Collaborations
Rangineni has collaborated with several professionals in his field, including Thirumalai Rajan Srinivasan and Eswaraiah Sajja. These collaborations have likely enhanced the quality and scope of his research, leading to successful patent applications.
Conclusion
Srinivasulu Rangineni's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in drug formulation and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile